The Current Situation Clause Samples

The Current Situation. 8.1. This RM6172 Grant Administration Services DPS Agreement is a replacement for RM949 Grants and Programme Services Framework which offers access to third-party suppliers in the grant administration space to central government the wider public sector and all third sector organisations. These suppliers are accessed to help and support central government and wider public sector in delivering their various grants programmes. The agreement is due to expire in October 2020. 8.2. RM949 Grants and Programme Services Framework was set up as part of the Government Efficiency Programme strategy to provide granting authorities with tools to drive efficiencies in the grant making process including through the use of third party suppliers. A predecessor took the form of the Civil Society Grant Fund Administration Services Framework (ref F323) and had the Cabinet Office as the contracting authority. 8.3. The new RM6172 Grant Administration Services DPS Agreement will offer a wide range of Services that are required as part of the six-step process of grant funding as outlined by the Cabinet Office via the Grants Centre of Excellence and the Government Grants Management Function.

The Current Situation. This RM6094 Spark DPS Agreement is a new offering from CCS. Having reviewed our approach to emerging technologies we are pursuing a new approach for immature markets that enables Customers access to genuine innovation and Suppliers a route to market which is adaptable as their capabilities change. Outside of the cloud software and services at present CCS does not have any commercial offerings associated with the provision of new products emerging from technology innovation, such as those developed as proof of concepts between a public sector customer and a supplier. This DPS will form one part of a wider programme of work to provide advice and guidance to Customers in order to ensure the right commercial and Supplier relationship approaches to innovation are being taken and that barriers to successful exploitation of innovation are not unnecessarily created. This includes a focus on a collaborative relationship and a balanced approach to risk within the contract.

The Current Situation. While a large number of ARV drugs currently in use are under patent, most of these drugs can be made available on the international market as less expensive generics. Moreover, at least nine ARVs are due to come off-patent by 2010.6 Although the numbers are increasing slowly, few developing countries have the technical capacity or the resources to produce generic varieties of ARV drugs. Even though patent protection of ARVs in developing countries has taken place in an ad hoc fashion, with the increasing com- pliance of developing countries to the provisions of TRIPS, brand name drug companies are beginning to be able to patent their products in more countries. In addition, a number of Least Developed Countries (LDCs) have already enacted legislation which extends patent protection to pharmaceutical products de- spite being exempted from having to afford patent protection to pharmaceutical products until 2016.7 Two primary developments with the World Trade Organization (WTO) have played a role in expediting the availability of generic ARVs: the landmark Doha Declaration on TRIPs and Public Health (Doha Declara- tion) and the WTO General Council Decision of 30 August 2003 (30 August Decision). The Doha Declara- tion clarified once and for all, the debate around the ability of developing countries to issue compulsory licenses where necessary, in the interests of public health. As such it was a turning point for developing and least-developed countries which have the capacity to manufacture generic drugs. While this was a significant step, the reality is that most developing countries do not have a sufficiently large manufactur- ing industry to satisfy the demand for generic drugs in their own countries. This meant that a pathway to access generic drugs for countries with insufficient manufacturing capacity remained elusive. For that reason, a deadline was set by WTO members (for the end of 2002) by which a solution should be found for these countries to have a way to access essential medicines.

The Current Situation. 2.1 The Agreements between the authorities which include the Joint Transportation Boards Terms of Reference are usually reviewed every four years. This period has now lapsed and a new agreement is required to be put in place, as previously indicated there have been some amendments to the agreement.

The Current Situation. A. The Present Issues 1. Hong Kong’s “Democracy” Has an Expiration Date Many of the Hong Kong protestors have demanded democracy from Beijing, as though it was something promised to them in the Basic Law. 36 A closer look at the Basic Law and the Joint Declaration, which created the Basic Law, however, suggests that Hong Kong’s political status after 2047 is at best uncertain, if not certain to be subsumed into the Chinese Communist Party system.37 Despite language clearly stating that Hong Kong will enjoy a “high degree of autonomy,” maintain its capitalist system, and retain independent judicial power, Article 3 of the Joint Declaration introduces a caveat, stating that the foregoing policies “will be stipulated, in a Basic Law of the Hong Kong Special Administrative Region . . . and will remain unchanged for 50 years.”38 There are areas in the Basic Law that are clear indicators of Hong Kong’s status as a democracy, enumerating rights for its citizens including the right to vote and the right to stand for election.39 However, no matter what the Basic Law states, there is ▇▇ ▇▇▇▇▇▇▇ ▇▇▇, Hong Kong’s Future: Police State or Mob State?, FOREIGN POLICY (Oct. 25, 2019, 5:49 PM), ▇▇▇▇▇://▇▇▇▇▇▇▇▇▇▇▇▇▇.▇▇▇/2019/10/25/hong- kong-protests-future-china-police-mob/.